Tweets
Study of 9558 pts found significant associations betw migraine and CTS Median nerve decompression (OR, 1.3) & multiple nerve decompressions (OR, 1.7). Also assoc w/ migraine: psych dz, RA, CVS, hypothyroid, HTN, COPD https://t.co/cIdkACHGwB https://t.co/VO3VqujzSQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Real world interchangeabilty study compared rituximab to biosimilar ( CT-P10) in 128 Rheum pts (CT-P10= 64; RTX= 64), with 41% of pts switched from RTX to CT-P10. Both Rx had Comparable Gr 2 infuxion Rxs, infection #s & hypogammaglobulinemia (p > 0.05) https://t.co/RNxt7Xn7MJ https://t.co/u3yJNQQIMC
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Doctor’s Contracts: Pitfalls and Traps
Dr. Dao ( @KDAO2011) spoke with Andrea Liberatore, JD, to explain what to look for in a contract.
https://t.co/w44pWWyhpo https://t.co/fy5vlve4IQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Retrospective study on prescribing by male vs female RHEUMs, found that women (in private practice, >10 yrs) were less likely to be High steroid prescribers. RA Pts more likely to Rx steroids = male sex, >prior biologics, opioid use, w/ comorbidities & freq infx https://t.co/eO3yJRCfOR
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
The European Commission has approved upadacitinib (Rinvoq) for the Treatment of Moderately to Severely Active Crohn's Disease https://t.co/Clzca7jU5b https://t.co/nNFGe5fF25
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
12 mos. serial study of 71 pts with gout found 42% with at least 1 gout flare (median=2) over 12 mos. US eval. showed "Flare" pts had signif more MSU deposits (6.7 vs 2.9) & power Doppler (3.73 vs 0.82)vs controls. By US- were 17-29% more likely to flare. https://t.co/icDyNEsCa6 https://t.co/86pgBzG9MC
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Lillys IL-23 inhibitor (Mirakizumab) has suffered a minor setback receiving a "complete response letter" from the FDA regarding MIRA application (BLA) for use in ulcerative colitis. The CRL hold up is related to the manufacturing issues (not data/safety) https://t.co/Xs93pFNFAp https://t.co/vlVP8qiqGr
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Pain and Opioid Updates
The CDC and FDA provided new updates on the scope of pain in the USA and guidance on the use of opioids.
https://t.co/jjN9zvX7rV https://t.co/kY3kX1S8vq
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Retrospective study of 147 THA and TKA pts w/ acute/chronic complaint - 39 pts Dx w/ prosthetic joint infection (PJI). Absolute numbers of neutrophils (PMNs) best predicted PJI (THA > 3,600 PMN/µl; TKA >2,000 PMN/µl (sensitivity 97%; specificity 93.5%) https://t.co/pxKcsTT6tn https://t.co/IQZ0DSUxwc
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Best Treatments for Immune Checkpoint Inhibitor-associated Arthritis
A retrospective study of cancer patients who developed ICI-IA shows that biologic DMARDs were more effective than csDMARDs in rapid control of arthritis.
https://t.co/EQjSgav0by https://t.co/CZ0IqR3UXM
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
Clinical Profile of RA-associated Interstitial Lung Disease
A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history.
https://t.co/FazEGcHh5H https://t.co/oh6oIpj21k
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago
4/18 Tuesday Night Rheumatology: Private Practice & Academia
Our panelists will address the big questions of: "How do I choose between private practice and academia?" and "How do I advance in my career?"
Sign up for this session and all sessions here:
https://t.co/TrMpNmHpj3 https://t.co/3vIwxK0CUU
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 2 months ago


